LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
MCF 10A XMD16-144
0.37
uM
LJP5
3
M10
72
hr
513 1347 10483 0.1285 0.2481
MCF 10A XMD16-144
1.11
uM
LJP5
1
M09
72
hr
513 1177 10254 0.1148 0.2117
MCF 10A XMD16-144
1.11
uM
LJP5
2
M09
72
hr
513 1437 10349 0.1389 0.2681
MCF 10A XMD16-144
1.11
uM
LJP5
3
M09
72
hr
513 1295 10483 0.1235 0.2369
MCF 10A XMD16-144
3.33
uM
LJP5
1
M08
72
hr
513 1406 10254 0.1371 0.2627
MCF 10A XMD16-144
3.33
uM
LJP5
2
M08
72
hr
513 1353 10349 0.1307 0.2506
MCF 10A XMD16-144
3.33
uM
LJP5
3
M08
72
hr
513 1133 10483 0.1081 0.1995
MCF 10A XMD16-144
10
uM
LJP5
1
M07
72
hr
513 562 10254 0.0548 0.0212
MCF 10A XMD16-144
10
uM
LJP5
2
M07
72
hr
513 791 10349 0.0764 0.1049
MCF 10A XMD16-144
10
uM
LJP5
3
M07
72
hr
513 594 10483 0.0567 0.0341
MCF 10A Erlotinib
0.04
uM
LJP5
1
M24
72
hr
513 9864 10254 0.9619 0.9821
MCF 10A Erlotinib
0.04
uM
LJP5
2
M24
72
hr
513 9672 10349 0.9345 0.9690
MCF 10A Erlotinib
0.04
uM
LJP5
3
M24
72
hr
513 10242 10483 0.9770 0.9893
MCF 10A Erlotinib
0.12
uM
LJP5
1
M23
72
hr
513 8565 10254 0.8352 0.9184
MCF 10A Erlotinib
0.12
uM
LJP5
2
M23
72
hr
513 8748 10349 0.8453 0.9239
MCF 10A Erlotinib
0.12
uM
LJP5
3
M23
72
hr
513 8522 10483 0.8129 0.9070
MCF 10A Erlotinib
0.37
uM
LJP5
1
M22
72
hr
513 2292 10254 0.2235 0.4139
MCF 10A Erlotinib
0.37
uM
LJP5
2
M22
72
hr
513 2089 10349 0.2018 0.3825
MCF 10A Erlotinib
0.37
uM
LJP5
3
M22
72
hr
513 2690 10483 0.2566 0.4631
MCF 10A Erlotinib
1.11
uM
LJP5
1
M21
72
hr
513 591 10254 0.0576 0.0331
MCF 10A Erlotinib
1.11
uM
LJP5
2
M21
72
hr
513 667 10349 0.0644 0.0623
MCF 10A Erlotinib
1.11
uM
LJP5
3
M21
72
hr
513 620 10483 0.0591 0.0443
MCF 10A Erlotinib
3.33
uM
LJP5
1
M20
72
hr
513 616 10254 0.0601 0.0431
MCF 10A Erlotinib
3.33
uM
LJP5
2
M20
72
hr
513 697 10349 0.0673 0.0731
MCF 10A Erlotinib
3.33
uM
LJP5
3
M20
72
hr
513 688 10483 0.0656 0.0696